Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

view_cart
☰

Clobetasol

Clobetasol
In stock
30g · 15g
from A$34.13
Strength
Pack size — the bigger the pack, the cheaper the tablet
A$97.96A$81.63
A$27.21 per tube

In brief

  • In our pharmacy, you can buy clobetasol without a prescription, with delivery in 3–14 days throughout Australia. Discreet and anonymous packaging.
  • Clobetasol (clobetasol propionate) is a super‑potent topical corticosteroid used short‑term for severe inflammatory skin disorders such as psoriasis, eczema and other steroid‑responsive dermatoses; it binds glucocorticoid receptors to suppress inflammation and immune activity in the skin.
  • The usual dose is a thin layer applied to affected skin 1–2 times daily for a short course; scalp solutions may be used twice daily and shampoos are often used once daily. Common label limits include treatment for up to 2 consecutive weeks and a maximum of about 50 g or 50 mL per week.
  • Administration is topical: cream, ointment, gel, foam, lotion, scalp solution or shampoo (and specialised ophthalmic formulations in some markets); apply externally to the affected area as directed.
  • Onset: many people notice symptom improvement within 24–72 hours, with some relief beginning within hours of first application.
  • Duration of action: anti‑inflammatory effects typically last around 12–24 hours per application; overall treatment courses are kept short (commonly up to 2 weeks) to reduce adverse effects.
  • Alcohol warning: there is no specific interaction with moderate alcohol intake, but avoid applying alcohol‑based products to treated skin and excessive alcohol may impair skin healing or increase risk of complications.
  • The most common side effect is local skin thinning (atrophy) and irritation (burning, stinging, redness); prolonged or extensive use can also cause HPA‑axis suppression and other steroid‑related complications.
  • Would you like to try clobetasol without a prescription?

Basic Clobetasol Information

  • INN (International Nonproprietary Name): Clobetasol Propionate
  • Brand Names Available In Australia: CLOXOBET Cream 0.05%
  • ATC Code: D07AD01 — Dermatologicals, Corticosteroids, Very Potent (Group IV)
  • Forms & Dosages: Cream; Ointment; Scalp Solution/Shampoo; Lotion; Gel; Foam; Occasional Ophthalmic Suspension in some markets
  • Manufacturers In Australia: Not Specified
  • Registration Status In Australia: Not Specified
  • OTC / Rx Classification: Prescription-Only (Rx)

Critical Warnings, Patient Protection And Immediate Safety (Australia)

Clobetasol 0.05% is a super‑potent topical corticosteroid and must be used only under medical or pharmacist supervision.

The active INN is clobetasol propionate and its ATC code is D07AD01, indicating very high potency.

Products containing clobetasol propionate 0.05% are generally prescription-only and labelled for short courses to limit harm.

Limit duration and total amount to reduce risk of local and systemic adverse effects, including skin atrophy and hypothalamic–pituitary–adrenal (HPA) axis suppression.

If a product label gives a weekly maximum (for example 50 g or 50 mL per week), follow that guidance and seek review if symptoms persist.

High‑Risk Groups (Elderly, Pregnancy, Children, Comorbidities)

  • Pregnancy: Use with caution and only if clearly needed; many products are prescription-only and require prescriber assessment.
  • Breastfeeding: Apply to unaffected areas when possible and avoid nipple contact if used on the chest.
  • Children: Several clobetasol formulations are not recommended under 18 and use in children is restricted.
  • Elderly: Reduce area and avoid prolonged use because thin skin increases absorption and atrophy risk.
  • Immunosuppressed Patients: Increased infection risk and altered healing; use specialist advice for extensive disease.
  • Diabetes: Monitor skin infections and healing where large areas are treated.
  • Large Surface‑Area Application: Greater systemic absorption and HPA‑axis risk; monitor and minimise exposure.
  • Skin Infections: Avoid use where active bacterial, viral or fungal infection is present unless treating the infection concurrently.
  • Thin Skin Areas: Generally avoid face, eyelids, genital and groin areas unless specialist prescribes lower potency or special regimen.
  • Recent Live Vaccines: Consider delaying use of potent steroids over large areas or seek clinician advice if systemic exposure is possible.

Interaction With Activities & Workplace Safety

  • Do not use high‑occlusion dressings unless specifically advised by a clinician due to increased absorption risk.
  • Avoid applying before manual work that risks skin damage or contamination, such as gardening or food handling.
  • Heat exposure and sweating can increase absorption; avoid heavy exercise or sauna immediately after application to treated large areas.
  • Topical clobetasol can delay wound healing if applied to open or damaged skin.
  • If your job requires sterile technique or food safety, discuss timing of application with your pharmacist.

Q&A — Can I Drive After Taking It In Australia?

Short answer: topical clobetasol does not impair driving.

If you experience dizziness or visual changes, which are rare and more likely with extensive systemic exposure or ophthalmic formulations, do not drive and seek advice.

Contact Where To Call
Chemist Warehouse Ask the pharmacist in store or via their helpline
Priceline Pharmacy Pharmacist consultation at store or phone
Local GP Book an appointment for urgent review

Usage Basics: Names, Forms And Legal Classification In Australia

What is this medicine called and how does it come? Many patients ask for brand names or the active ingredient.

INN, Common Brand Names Available Locally

The INN is clobetasol propionate and the common strength is 0.05% w/w or w/v depending on formulation.

International brand names include Dermovate and Clobex, while an Australian example is CLOXOBET cream 0.05%.

Typical forms available in markets are cream, ointment, scalp solution or shampoo, lotion, gel and foam, with specialised ophthalmic suspensions in some countries.

Legal Status — TGA, Prescription And PBS Context

Clobetasol 0.05% products are listed as prescription-only in the data provided.

Some formulations may be TGA-registered but are not necessarily listed on the Pharmaceutical Benefits Scheme (PBS) for subsidy.

  • TGA: Therapeutic Goods Administration.
  • PBS: Pharmaceutical Benefits Scheme.

Dosing Guide And Practical Limits (Australian Context)

People want to know how much to use and for how long without causing harm.

Standard Regimens And PBS Reference Dosing

Typical adult dosing for plaque psoriasis and severe eczema is a thin layer to the affected skin one to two times daily for a short course.

Scalp solutions or shampoos have product-specific instructions and some solutions are used twice daily while shampoos are often once daily.

Common label guidance limits duration to up to two consecutive weeks and often caps use at around 50 g or 50 mL per week.

Condition Formulation Typical Frequency
Plaque Psoriasis Cream / Ointment 1–2× Daily
Scalp Psoriasis Scalp Solution / Shampoo Solution: Up To 2× Daily; Shampoo: Per Product Instructions
Severe Lichenified Dermatoses Ointment / Cream 1–2× Daily Short Course

Adjustments For Comorbidities And Vulnerable Patients

  • Reduce treated area and duration in elderly patients and those with thin skin.
  • Avoid occlusion unless supervised by a specialist for selected cases.
  • Monitor for HPA-axis effects when treating large areas, using occlusion, or giving prolonged treatment.
  • Refer children to a paediatrician or dermatologist because use is restricted under 18 for many products.

Q&A — What If I Miss A Dose?

If you miss a dose, apply as soon as you remember that day and continue as prescribed.

Do not double up applications or exceed weekly maximums such as 50 g or 50 mL per week.

Contact your pharmacist or GP if you are unsure about dosing or have used more than advised.

Interaction Chart — What To Avoid Or Monitor

Topical clobetasol has few food or drink interactions, but lifestyle and concurrent medications matter for skin disease control.

Food, Drink And Lifestyle Interactions (Australia)

  • Topical clobetasol has negligible direct food or drink interactions.
  • Smoking, high alcohol intake, obesity and stress can worsen psoriasis or eczema control and should be addressed holistically.
  • Poor nutrition and heavy alcohol use may complicate healing and immune responses.

Common Drug And Topical Conflicts

Interaction What To Watch For
Concomitant Systemic Corticosteroids Increases total systemic steroid load and risk of HPA-axis suppression if topical absorption is significant
Large-Area Or Occluded Topical Use Higher systemic absorption and potential adrenal suppression
Topical Calcineurin Inhibitors On Same Area Avoid using both on the same area without advice due to conflicting effects and irritation risk
Live Vaccines Consider caution if systemic exposure to steroids is suspected; seek clinical guidance
  • HPA‑axis suppression: Reduced adrenal cortisol production from systemic steroid exposure.

User Reports, Patient Experience And Trends (Australia)

Patients commonly report fast symptomatic relief with short courses of clobetasol for severe plaques or scalp flares.

Typical online forum and pharmacy consultation themes include rapid control but concerns about atrophy and rebound when stopped abruptly.

  • Positive: Fast relief of severe plaques, clear effect on itch and scaling, convenient cream or scalp solution options.
  • Negative: Skin thinning with prolonged use, striae, tachyphylaxis, irritation on sensitive areas, and rebound flares on sudden cessation.
Sentiment Approximate Anecdotal Share
Favourable ~60% (anecdotal reports and forum praise for quick control)
Adverse / Concerned ~40% (atrophy, rebound, misuse for extended periods)

Clinicians should validate online reports against clinical evidence and TGA/PBS guidance before changing management.

Access And Purchase Options In Australia

Where to get clobetasol and how to plan for supply are common patient concerns.

National Pharmacy Chains And Face‑To‑Face Access

  • Chemist Warehouse, Priceline and TerryWhite Chemmart dispense clobetasol by prescription and stock varies by formulation.
  • Call ahead to confirm availability for cream, ointment or scalp solution and to reserve stock.

Online Pharmacies, Telehealth And E‑Prescriptions

Pathways include a GP or telehealth consult which produces an electronic prescription that can be sent to a community or online pharmacy.

Rural patients may face longer dispensing times and occasional supply interruptions.

  • Verify PBS status and whether your chosen brand or generic is available.
  • Confirm formulation and pack size with the pharmacist and ask about weekly quantity limits such as 50 g/week.
  • Ask the pharmacist for counselling on application and review timing.

In our online pharmacy, clobetasol is available without a prescription, with discreet delivery to Australia in 9-21 days.

Mechanism Of Action And Pharmacology (Plain Language + Clinical Terms)

Patients often ask how clobetasol works and why it is so potent.

Simplified Explanation For Patients

Clobetasol reduces inflammation and immune activity in the skin by activating corticosteroid receptors.

The result is less redness, itch and scaling as inflamed cells shrink and immune signals are dampened.

Clinical Terms And Pharmacology Details

The INN is clobetasol propionate at strength 0.05% w/w or w/v depending on formulation.

Its ATC classification is D07AD01 which places it in the very high potency topical corticosteroid group.

  • Onset of action: symptomatic improvement is often seen quickly, which is why short courses give rapid relief.
  • Local vs systemic absorption: absorption increases with damaged skin, occlusion, thinner skin and larger treated areas.
  • Potency classification: Group IV, very high potency, so use is limited by labels and guidelines.

For clinician handouts, a simple flowchart can show receptor binding leading to gene modulation and anti-inflammatory effect.

Indications And Common Off‑Label Uses In Practice

Clinicians and patients want clarity on when clobetasol is appropriate and when specialist input is needed.

Approved Indications (TGA/Labelled Uses)

Clobetasol 0.05% is indicated for short‑term treatment of severe inflammatory skin disorders such as psoriasis and other corticosteroid‑responsive dermatoses.

Scalp-specific formulations exist for scalp psoriasis and related scalp dermatoses.

Indication Recommended Formulation
Severe Plaque Psoriasis Cream / Ointment
Scalp Psoriasis Scalp Solution / Shampoo
Corticosteroid‑Responsive Dermatoses Topical 0.05% Formulation Short Course

Off‑Label Uses And Cautions

  • Off‑label use may include stubborn lichenified eczema and palmoplantar psoriasis but requires specialist input and a clear short‑term plan.
  • Avoid use on the face and intertriginous areas unless a specialist chooses an appropriate lower potency or alternate therapy.
  • Clinicians should confirm diagnosis, document the treatment plan and obtain informed consent describing risks like atrophy and HPA suppression.

Key Clinical Findings And Safety Evidence (Recent Reviews)

What do reviews and guideline summaries say about super‑potent steroids like clobetasol?

They provide rapid short‑term control of severe plaques and resistant dermatitis but carry higher risks when used long term or over large areas.

  • Monitor for local atrophy, telangiectasia and striae with cumulative exposure.
  • Watch for secondary infection and rebound on abrupt cessation.
  • Systemic steroid effects such as fatigue or Cushingoid features can occur with significant absorption.

Evidence through recent years supports short courses commonly up to two weeks and label weekly maxima such as 50 g or 50 mL to reduce risk.

Consult up‑to‑date systematic reviews and Australasian dermatology guidance for the latest recommendations.

Alternatives Matrix — Topical And Systemic Options

When clobetasol is unsuitable, there are topical and systemic alternatives to consider.

PBS‑Listed Alternatives Comparison Table

Drug Potency Typical Use PBS Status Pros Cons
Betamethasone High Moderate‑to‑severe inflammatory lesions Varies By Formulation Effective, less potent than clobetasol Still risk of atrophy with prolonged use
Mometasone Potent Inflammatory dermatoses Varies Potent with good tolerability May be insufficient for very resistant plaques
Hydrocortisone Mild Face, folds, children Often OTC Low‑Strength; Rx For Higher Strength Low risk of atrophy Not for severe lesions
Calcipotriol (Vitamin D Analogue) Steroid‑Sparing Psoriasis Maintenance Often PBS‑Listed For Psoriasis Reduces steroid exposure Irritation risk in some patients
Systemic Agents (Methotrexate, Biologics) Systemic Severe Widespread Psoriasis PBS Criteria Apply Control severe disease Systemic risks, monitoring required

Pros And Cons Checklist For Switching

  • Consider site of disease, severity and history of response before switching.
  • Account for pregnancy, breastfeeding and age when choosing alternatives.
  • Follow PBS criteria before escalating to systemic therapy and obtain necessary approvals.
  • Adopt a step‑down strategy: once controlled, move to lower potency or steroid‑sparing maintenance.

Common Pharmacy Questions And Brief Answers (Australian Context)

Here are short answers to the questions patients ask at the counter.

  • How long can I use it? Short courses commonly up to two weeks; follow prescriber advice and label limits such as 50 g/mL per week.
  • Can I apply to my face? Generally avoid face and intertriginous areas unless a specialist prescribes specific guidance or a lower‑potency option.
  • What about children? Many formulations are restricted under 18; refer to a paediatrician or dermatologist.
  • What happens if I stop suddenly? Rebound flares can occur; tapering or switching to a lower potency under clinician advice may be required.
  • Can I use other creams at the same time? Avoid using potent topical steroids and topical calcineurin inhibitors on the same area without professional advice.

Refer patients back to GP or dermatologist if lesions do not improve within the expected short course or if adverse effects arise.

Price, Subsidy And Access Comparison (Table + Checklist)

Price & Source Comparison Table

Provider Typical Price Range (Private Pay) PBS Subsidy Status Prescription Required
Chemist Warehouse Varies By Brand / Formulation Check PBS Site Yes — Rx
Priceline Pharmacy Varies By Brand / Formulation Check PBS Site Yes — Rx
TerryWhite Chemmart Varies By Brand / Formulation Check PBS Site Yes — Rx
Online Pharmacy Varies; generics often cheaper Check PBS Site Yes — Rx or e‑prescription

Access Checklist For Patients

  • Check whether the product is PBS‑listed and if you are eligible for subsidy.
  • Ask for a generic substitution if cost is a concern.
  • Confirm pack size and quantity match the prescription and weekly limits.
  • Request a counselling session when picking up the prescription for application technique and review timing.
  • Consider prior authorisation for PBS‑sponsored systemic alternatives if required.

Registration, Regulation And Reporting (TGA & PBS)

Regulatory clarity helps clinicians and patients manage risk and report problems.

TGA Approval Considerations

Clobetasol 0.05% formulations are regulated medicines and many markets treat them as prescription-only products.

Confirm TGA registration for the specific brand and formulation when advising patients in Australia.

PBS Subsidy And Adverse‑Event Reporting

  • Clinicians should check PBS listings and criteria before prescribing subsidised alternatives.
  • Report suspected serious adverse events through the TGA adverse event reporting scheme.
  • Report if systemic symptoms, severe local reactions or unintended pregnancy exposure occur after use.

Storage, Handling And Disposal (Practical Australian Advice)

Safe storage and responsible disposal reduce risk at home and in the community.

Household Storage (Heat And Humidity Considerations)

  • Avoid direct heat and sunlight; follow the product label but store below 25–30°C where indicated.
  • Keep out of reach of children and avoid storing in humid places like the bathroom when possible.
  • Do not freeze topical formulations and keep them in their original container with the cap closed.
  • Discard after expiry and return unwanted medicine to a pharmacy take‑back point.

Pharmacy Cold‑Chain And Supply Handling

Most clobetasol products require ambient storage unless the label specifies otherwise.

Pharmacies should manage stock rotation and notify remote patients of supply delays.

Item Typical Temp / Handling
Cream / Ointment Ambient; protect from heat and sunlight
Shampoo / Solution Ambient; avoid freezing
Disposal Return to pharmacy for medicine take‑back

Guidelines For Proper Use And Australian Pharmacist Counselling

Clear counselling reduces misuse and improves outcomes.

Counselling Script And Key Messages (Pharmacist Style)

  • Confirm the diagnosis and the exact area to be treated before giving dosing advice.
  • Explain that clobetasol is very potent and intended for short courses to limit harm.
  • Demonstrate applying a thin layer and explain fingertip unit guidance for body areas.
  • State the weekly maximum (for many products commonly around 50 g or 50 mL per week) and set a review date.
  • Warn to stop and seek medical review for signs of infection, severe irritation, skin breakdown or systemic symptoms.

Patient Resources & Follow‑Up (PBS And National Authorities)

  • Provide a written action plan and signpost to PBS factsheets and TGA consumer information for reference.
  • Arrange follow-up in two weeks or sooner if lesions worsen or adverse effects appear.
  • Refer to a dermatologist if disease is widespread, recurrent or requires longer-term management.

Delivery Across Australia

City Region Delivery Time
Sydney New South Wales 9-14 Days
Melbourne Victoria 9-14 Days
Brisbane Queensland 9-14 Days
Perth Western Australia 9-14 Days
Adelaide South Australia 9-14 Days
Canberra Australian Capital Territory 9-14 Days
Hobart Tasmania 9-14 Days
Darwin Northern Territory 9-14 Days
Gold Coast Queensland 14-21 Days
Newcastle New South Wales 14-21 Days
Wollongong New South Wales 14-21 Days
Cairns Queensland 14-21 Days
Townsville Queensland 14-21 Days
Geelong Victoria 14-21 Days
Ballarat Victoria 14-21 Days

Related products